期刊文献+

探讨癌结节在结直肠癌患者术后病理分期中的意义及其对预后的价值研究 被引量:3

Study of tumor deposits′application in postoperative pathologic staging definition and the prognostic value in colorectal cancer patients
原文传递
导出
摘要 目的研究结直肠癌手术患者术后病理中癌结节的检出与患者预后的关系,探讨更加详细、合理的分期方法。方法收集2012年1月至2013年12月于安徽医科大学第一附属医院普外科行结直肠癌切除术的361例患者的临床及随访资料,采用Kaplan-Meier生存曲线比较生存差异,COX单因素和多因素分析影响结直肠癌患者预后的相关因素。结果术后病理中癌结节检出与否和肿瘤的分化程度、肿瘤的浸润深度(T)、pTNM分期、CEA、CA19-9相关,差异具有统计学意义(均P<0.05);单因素分析癌结节阴性患者生存时间长于癌结节阳性患者,差异具有统计学意义(χ^2=10.805,P<0.05);将N0、N1c、N1和N2的患者进行生存比较,发现N1c和N1的患者之间差异无统计学意义(χ^2=0.580,P>0.05);随着癌结节数目的增加,患者的生存预后越差;当把癌结节当成转移淋巴结时,得到新的分期与第八版TNM分期的生存比较存在差异:当对癌结节数目、转移淋巴结数目和总检出淋巴结数目进行研究时发现,随着阳性结节比值(癌结节数+转移淋巴结数)/(癌结节数+病理检出淋巴结总数)的增加,患者的预后也随之变差(59.4 vs.58.2 vs.36.0 vs.28.7,χ^2=15.389;P=0.002)。结论癌结节的状态是影响结直肠癌患者预后的重要因素,将癌结节及转移淋巴结均定义为阳性结节后,阳性结节比值越高的患者预后越差;阳性结节比值可作为评估结直肠癌患者TNM分期中的重要补充,为指导日后治疗提供更准确的依据。 Objective Our study aims to investigate the relationship between postoperative pathological tumor deposits and the prognosis of patients with colorectal cancer surgery,investigating a detailed and reasonable method in tumor staging.Methods The clinical and follow-up data of 361 patients who underwent colorectal cancer resection in the General Surgery Department of the First Affiliated Hospital of Anhui Medical University from January 2012 to December 2013 were collected.Kaplan-Meier survival curve was used to compare the survival differences.Cox single factor and multi factor analysis were used to analyze the related factors affecting the prognosis of colorectal cancer patients.Results Postoperative tumor deposits positive or not was related to the degree of tumor differentiation,tumor infiltration depth(T),pTNM,CEA and CA19-9,founding statistical significance(all P<0.05).The survival time of patients with tumor deposits negative was higher than that of patients with tumor deposits positive in univariate ananlysis(χ^2=10.805,P<0.05).After analyzing,we found that patients with stage N1 and N1c having no survival different(χ^2=0.580,P>0.05).However,when the number of tumor deposits was increasing,the survival prognosis of patients was getting worse.When the tumor deposits were treated as metastatic lymph nodes,modified staging was obtained and having statistical difference from the 8th editing TNM staging.When it comes to the number of tumor deposits,metastatic lymph nodes number and the detected total lymph nodes number,we found that patients with high positive nodes ratio(tumor deposits+metastatic lymph nodes)/(total number of all nodes)have bad survival outcomes(59.4 vs.58.2 vs.36.0 vs.28.7,χ^2=15.389;P=0.002).Conclusions Tumor deposits status are the important factor affecting the prognosis of patients with colorectal cancer.When we defining positive tumor deposits and metastatic lymph nodes as positive nodes,the patients with high positive nodes ratio would have bad prognosis.Positive nodes ratio can be used as important supplement for TNM staging of colorectal cancer patients,providing a more accurate basis for guiding treatment in the future.
作者 胡正宇 李彦 陈博 杨群树 齐向咏 孟翔凌 Hu Zhengyu;Li Yan;Chen Bo;Yang Qunshu;Qi Xiangyong;Meng Xiangling(Department of Surgery,the First Affiliated Hospital of Anhui Medical University,Hefei 230022,China;Department of Radiotherapy,the First Affiliated Hospital of Anhui Medical University,Hefei 230022,China)
出处 《中华结直肠疾病电子杂志》 2020年第2期137-143,共7页 Chinese Journal of Colorectal Diseases(Electronic Edition)
基金 安徽省科技计划项目(No.1607a0202020)。
关键词 结直肠肿瘤 癌结节 TNM分期 预后 Colorectal neoplasms Tumor deposit Stage TNM Prognosis
  • 相关文献

参考文献2

二级参考文献16

  • 1张晓雨,周建农,张彤.survivin、VEGF及Ki67在结直肠癌中的表达及其临床意义[J].肿瘤防治研究,2007,34(1):35-38. 被引量:18
  • 2吴在德,吴肇汉.外科学[M]人民卫生出版社,2003.
  • 3National Comprehensive Cancer Network [J]. NCCN ClinicalPractice Guidelines in Oncology: colorectal cancer, V.2.2015.
  • 4Ismaili N. Treatment of colorectal liver metastases [J]. World J SurgOncol, 2011, 9(1): 154.
  • 5Edge SB, Byrd DR, Compton CC. AJCC Cancer Staging Manual.7thed [J]. NY: Springer, 2010.
  • 6Gabriel WB, Dukes CE, Bussy HJR. Lymphatic spread in cancer ofthe rectum [J]. Br J Surg, 1935, 23: 395-413.
  • 7Sobin LH, Wittekind CH.UICC. TNM Classification on MalignantTumours. 5th ed [J]. New York, NY: Wiley-Liss Publications, 1997.
  • 8Sobin LH, Wittekind CH.UICC. TNM Classification on MalignantTumours. 6th ed [J]. New York, NY: Wiley-Liss Publications, 2002.
  • 9Nagtegaal ID, Tot T, Jayne DG, et al. Lymph Nodes, TumorDeposits, and TNM: Are We Getting Better? [J]. J Clin Oncol, 2011,29(18): 2487-2492.
  • 10Quirke P, Williams GT, Ectors N, et al. The future of the TNMstaging system in colorectal cancer: time for a debate? [J]. LancetOncol, 2007, 8(7): 651-657.

共引文献11

同被引文献20

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部